bioRxivSystems BiologyPreprint
Chronic Staphylococcus aureus infection is cured by theory-driven therapy
Lito A. PapaxenopoulouiD, Gang ZhaoiD, Sahamoddin KhailaieiD, Konstantinos Katsoulis‐Dimitriou, Ingo SchmitziD, Eva MedinaiD, Haralampos HatzikirouiD, Michael Meyer‐HermanniD
Abstract
Staphylococcus aureus is considered a dangerous pathogen due to its ability to evade the immune system and resist multiple antibiotics. These evasive strategies lead to difficult-to-treat chronic infections and abscesses in internal organs including kidneys, which are associated with the expansion of myeloid-derived suppressor cells (MDSCs) and their suppressive effect on T cells. Here, we developed a mathematical model of chronic S. aureus infection that incorporates the T-cell suppression by MDSCs and suggests therapeutic strategies to eradicate S. aureus. We quantified in silico a therapeutic protocol with heat-killed S. aureus (HKSA), which we tested in vivo. Contrary to conventional administration of heat-killed bacteria as vaccination prior to infection, we administered HKSA as treatment, when the hosts were already chronically infected. Our treatment cured all chronically S. aureus-infected mice, reduced MDSCs, and reversed T-cell dysfunction by inducing acute inflammation during ongoing, chronic infection without any use of standard treatments that involve antibiotics, MDSC-targeting drugs (chemotherapy), or procedures such as abscess drainage. This study is a proof-of-principle for a treatment protocol against chronic S. aureus infection and renal abscesses by repurposing heat-killed treatments, guided and quantified by mathematical modelling. Our mathematical model further explains why previous treatment with inactivated S. aureus administered to long-term infected human patients has not led to cure. Overall, our results can have direct relevance to the design of human therapeutics against chronic S. aureus infections. In briefA theory-driven treatment protocol with heat-killed S. aureus eradicates S. aureus, reduces MDSCs, and reverses T-cell dysfunction in vivo. Graphical abstract O_FIG O_LINKSMALLFIG WIDTH=157 HEIGHT=200 SRC="FIGDIR/small/910786v3_ufig1.gif" ALT="Figure 1"> View larger version (66K): org.highwire.dtl.DTLVardef@1e2d0c9org.highwire.dtl.DTLVardef@1f97374org.highwire.dtl.DTLVardef@b0235org.highwire.dtl.DTLVardef@bdf2ee_HPS_FORMAT_FIGEXP M_FIG C_FIG
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Biofilm/Persister/Stationary Phase Bacteria Cause More Severe Disease Than Log Phase Bacteria II Infection with Persister Forms of Staphylococcus aureus Causes a Chronic Persistent Skin Infection with More Severe Lesion that Takes Longer to Heal and is not Eradicated by the Current Recommended Treatment in Mice
- Targeting host deoxycytidine kinase mitigates Staphylococcus aureus abscess formation
V. Winstel, E. R. Abt, … C. G. Radu·bioRxiv·Aug 18, 2023
- A Drug Combination Approach Targeting Both Growing Bacteria and Dormant Persisters Eradicate Persistent Staphylococcus aureus Biofilm Infection
- The staphylococcal type VII secretion system delays inflammatory cell death during macrophage infection
Richard D. Allen, Robeena Farzand, … Meera Unnikrishnan·bioRxiv·Oct 30, 2025
- A niche-specific role for ArlRS enables Staphylococcus aureus growth within Kupffer cells
Josefien W. Hommes, Lindsey M. Orthner, … Bas G. J. Surewaard·bioRxiv·Oct 10, 2026
- The Toxin Antitoxin MazEF Drives Staphylococcus aureus Chronic Infection
D. Ma, J. B. Mandell, … K. L. Urish·bioRxiv·Jun 30, 2019